Merck & Co., Inc. (MRK), based in Rahway, New Jersey, is a healthcare company. Valued at $264.2 billion by market cap, the ...

Merck announced April 16 it entered into a definitive agreement to acquire San Diego-based biotechnology company Prometheus Biosciences Inc. for $200 per share in cash, representing a total equity ...

Merck (known as MSD outside of the United States and Canada) will complete its $9.2 billion acquisition of Cidara ...

Merck & Co. (MRK) is a global health care company that provides innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. Merck’s ...

Merck (MRK) stock achieved a 5-day winning streak, with total gains during this time reaching 6.9%. The company’s market ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its fourth-quarter and full-year 2025 ...

In a report released today, Courtney Breen from Bernstein maintained a Hold rating on Merck & Company. The company’s shares closed last Monday at $101.83. According to TipRanks.com, Breen is a 4-star ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of positive results from the Phase 1/2 study, V116-001, evaluating ...

Merck Foundation Chairman, Chief Executive Officer (CEO), and 14 First Ladies inaugurate the 7th Edition of Merck Foundation ...